Recent Finacing
Recent Raise
Cellivate Technologies develops cell-based serum to replace fetal bovine serum and engineered microcarriers to accelerate mammalian cell culture for scalable biomanufacturing of animal-free ingredients.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors